Related Experiment Video
Updated: Jun 5, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
The cautionary tale of side effects of chronic Notch1 inhibition
1Department of Cancer Biology, University of Pennsylvania School of Medicine, Abramson Family Cancer Research Institute, 311 BRB, 421 Curie Boulevard, Philadelphia, Pennsylvania 19106, USA. sryeom@upenn.edu
Abstract:
Aberrant Notch1 signaling is implicated in several types of cancer. Therefore, Notch signaling pathways are important anticancer targets. Pan-Notch receptor inhibition is associated with numerous complications; thus, selective Notch receptor inhibition has been pursued. Studies have shown minimal side effects with short-term blockade of either Notch1 or its ligand Delta-like 4, but long-term side effects were not investigated. In this issue of the JCI, Liu et al. use mouse models to demonstrate the consequence of long-term Notch1 inhibition. They present evidence that chronic Notch1 inhibition leads to vascular tumors in the liver and decreased survival, which suggests that Notch1 therapies should be reevaluated.
Insights
Long-term inhibition of Notch1 signaling, a potential cancer therapy target, unexpectedly caused liver vascular tumors and reduced survival in mice. These findings necessitate a reevaluation of Notch1-targeted cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Aberrant Notch1 signaling is a known factor in various cancers, making it a promising therapeutic target.
- Selective Notch receptor inhibition is preferred over pan-Notch inhibition due to potential complications.
- Previous studies indicated minimal side effects for short-term Notch1 or Delta-like 4 blockade, but long-term effects remained uninvestigated.
Discussion:
- This study investigates the long-term consequences of Notch1 inhibition using mouse models.
- Evidence suggests chronic Notch1 inhibition can induce adverse effects, specifically vascular tumors in the liver.
- The research highlights potential risks associated with prolonged therapeutic blockade of Notch1.
Key Insights:
- Chronic inhibition of Notch1 signaling in mice resulted in the development of hepatic vascular tumors.
- Long-term Notch1 blockade was associated with a significant decrease in overall survival.
- These preclinical findings challenge the safety profile of sustained Notch1 inhibition therapies.
Outlook:
- Further research is required to fully understand the long-term safety of Notch1-targeted therapies.
- Clinical strategies involving Notch1 inhibition may need reevaluation to mitigate risks of tumor development and reduced survival.
- Identifying alternative therapeutic approaches or refining existing ones is crucial for effective and safe cancer treatment.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Desensitization and Tachyphylaxis
Several...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Feedback Inhibition
